Cystic dystrophy in gastric heterotopic pancreas complicated by intracystic hemorrhage and fistulisation in the stomach - a pediatric case.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 18547764)

Published in Gastroenterol Clin Biol on June 10, 2008

Authors

C Stefanescu1, M-P Vullierme, A Couvelard, F Bretagnol, P Amouyal, F Maire, V Rebours, P Hammel, P Ruszniewski, P Lévy

Author Affiliations

1: Service de gastroentérologie-pancréatologie, pôle des maladies de l'appareil digestif, hôpital Beaujon, AP-HP, 92118 Clichy cedex, France.

Articles by these authors

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2006) 5.86

Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. J Clin Oncol (2005) 5.82

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. Ann Oncol (2008) 4.26

TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2007) 3.89

Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med (2001) 2.95

Clinical and genetic studies of Birt-Hogg-Dubé syndrome. J Med Genet (2002) 2.65

Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol (2000) 2.58

Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol (2004) 2.54

Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology (2005) 2.49

Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Study of 193 patients in two French sleep centers. Chest (1995) 2.45

Natural evolution of moderate sleep apnoea syndrome: significant progression over a mean of 17 months. Thorax (1997) 2.37

The natural history of hereditary pancreatitis: a national series. Gut (2008) 2.33

Characterization of obstructive nonapneic respiratory events in moderate sleep apnea syndrome. Am J Respir Crit Care Med (2001) 2.33

Splenic and portal venous obstruction in chronic pancreatitis. A prospective longitudinal study of a medical-surgical series of 266 patients. Dig Dis Sci (1992) 2.26

Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut (2002) 2.21

Primary malignant melanoma of the esophagus: a case report and review of the literature. Dis Esophagus (2002) 2.20

Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau. Gastroenterology (2000) 2.16

Assessment of complications of EUS-guided fine-needle aspiration. Gastrointest Endosc (2001) 1.94

CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J Cell Biol (1995) 1.93

Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut (2002) 1.85

Laparoscopic ventral rectopexy: a prospective long-term evaluation of functional results and quality of life. Tech Coloproctol (2013) 1.84

Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. Ann Oncol (2013) 1.82

Effective compliance during the first 3 months of continuous positive airway pressure. A European prospective study of 121 patients. Am J Respir Crit Care Med (1999) 1.73

Charcot-Marie-Tooth disease and sleep apnoea syndrome: a family study. Lancet (2001) 1.69

Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene. Ann Rheum Dis (2006) 1.67

Deficits of cognitive executive functions in patients with sleep apnea syndrome. Sleep (1995) 1.66

TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst (2012) 1.65

High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J (1999) 1.63

Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses. Gut (2000) 1.63

Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study. Eur Respir J (2009) 1.62

Expression of vascular endothelial growth factor in digestive neuroendocrine tumours. Histopathology (1998) 1.61

Murine platelet endothelial cell adhesion molecule (PECAM-1)/CD31 modulates beta 2 integrins on lymphokine-activated killer cells. Eur J Immunol (1993) 1.58

Hepatic arterial chemoembolization with streptozotocin in patients with metastatic digestive endocrine tumours. Eur J Gastroenterol Hepatol (2000) 1.57

Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas. Oncogene (2008) 1.57

Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas. Gastroenterology (1995) 1.51

[Pancreatic lesions in von Hippel-Lindau disease]. Ann Pathol (2000) 1.50

Cystic dystrophy of the gastric and duodenal wall developing in heterotopic pancreas: an unrecognised entity. Gut (1993) 1.47

Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA. Br J Cancer (2002) 1.47

[Sleep apnea syndrome: what do the general practitioners know?]. Rev Mal Respir (2002) 1.45

Exhaled nitric oxide during normoxic and hypoxic exercise in endurance athletes. Acta Physiol Scand (2005) 1.44

Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis. N Engl J Med (1993) 1.43

Prospective controlled study of endoscopic ultrasonography and endoscopic retrograde cholangiography in patients with suspected common-bileduct lithiasis. Lancet (1996) 1.42

[Enucleation of intraductal papillary-mucinous tumor of the head of the pancreas. Report of 2 cases]. Gastroenterol Clin Biol (2000) 1.42

Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study. J Clin Oncol (2002) 1.39

Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant (2008) 1.38

Functional and morphological changes in the pancreatic remnant following pancreaticoduodenectomy with pancreaticogastric anastomosis. Br J Surg (2000) 1.37

Prognostic factors in patients with endocrine tumours of the duodenopancreatic area. Gut (1998) 1.37

A new model of chronic intermittent hypoxia in humans: effect on ventilation, sleep, and blood pressure. J Appl Physiol (1985) (2009) 1.33

Relationship between body mass index, age and upper airway measurements in snorers and sleep apnoea patients. Eur Respir J (1996) 1.30

Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology (2000) 1.28

Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance. Cancer (2000) 1.26

Serum levels of pancreatitis-associated protein as indicators of the course of acute pancreatitis. Multicentric Study Group on Acute Pancreatitis. Gastroenterology (1994) 1.26

Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression. Br J Cancer (2005) 1.24

Splenic complications in chronic pancreatitis: prevalence and risk factors in a medical-surgical series of 500 patients. Br J Surg (1998) 1.24

14 nights of intermittent hypoxia elevate daytime blood pressure and sympathetic activity in healthy humans. Eur Respir J (2010) 1.23

Long-term wound advantages of the laparoscopic approach in rectal cancer. Br J Surg (2008) 1.22

Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology (1999) 1.22

[Genotyping of Toxoplasma gondii strains from immunocompromised patients]. Pathol Biol (Paris) (2000) 1.21

Operative results and quality of life after gracilis muscle transposition for recurrent rectovaginal fistula. Dis Colon Rectum (2009) 1.20

Choledocholithiasis: a prospective study of spontaneous common bile duct stone migration. Gastrointest Endosc (2000) 1.19

Increased p53 protein content of colorectal tumours correlates with poor survival. Br J Cancer (1992) 1.13

Accuracy of transvaginal sonography and rectal endoscopic sonography in the diagnosis of deep infiltrating endometriosis. Ultrasound Obstet Gynecol (2007) 1.13

Diagnosis of choledocholithiasis by endoscopic ultrasonography. Gastroenterology (1994) 1.12

Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis. Gut (2002) 1.10

Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome. Surgery (1995) 1.10

Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology (2005) 1.10

Current approach to the management of tumoral process in patients with gastrinoma. World J Surg (1986) 1.09

Predictive factors in the outcome of pseudocysts complicating alcoholic chronic pancreatitis. Gut (1997) 1.09

Cystic dystrophy of the duodenal wall in the heterotopic pancreas: radiopathological correlations. J Comput Assist Tomogr (2000) 1.09

The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors. Am J Gastroenterol (2000) 1.09

Differentiating obstructive and central sleep respiratory events through pulse transit time. Am J Respir Crit Care Med (1998) 1.09

Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea? Eur Respir J (2008) 1.08